PMP Series | Clonidine in Maine’s Carceral Setting: Pharmacology, Prescribing Practices, and Safety Considerations

This webinar will provide clinicians with a review of clonidine, including its pharmacological properties, mechanism of action, and key prescribing considerations across a range of clinical indications. Special attention will be given to the use of clonidine in patients with substance use disorder, including its role in managing withdrawal symptoms associated with opioid and alcohol use disorders and important safety considerations for this patient population. Use of clonidine for patients with justice-system involvement as well as in the community will be discussed.
Objectives:
  1. Describe pharmacological properties of clonidine as an alpha-2 adrenergic agonist
  2. Discuss evidence-based prescribing practices for clonidine across approved and off-label indications
  3. Discuss the role of clonidine in the management of patients with substance use disorder (SUD)

Presenters:

  • Jessika Morin, MD, Statewide Medical Director of Maine, Wellpath
  • Nicolette Centanni, PharmD, Clinical Pharmacist at Mainehealth Maine Medical Center, Portland Campus

Audience:

Prescribing Clinicians and their teams

Continuing Medical Education:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Hanley Center for Health Leadership and Education and CCSME. The Hanley Center for Health Leadership and Education is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.

The Hanley Center for Health Leadership and Education designates this regularly scheduled series for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

*Nurses and Nurse Practitioners will be awarded a certificate of participation with a maximum of 1 AMA PRA Category 1 Credit ™.

Contact Hours

1 contact hours for social workers, licensed clinical professional counselors, and behavioral health professionals.

1 Category 1 Contact hours for psychologists. CCSME is a pre-approved sponsor and provider of Professional Education Activities for Psychologists.

1 contact hours for Alcohol and Drug Counselors pending approval by the Maine Board of Alcohol and Drug Counselors

1 contract hours CHES. CCSME is a designated provider of continuing education contact hours (CECH) in health education by the National Commission of Health Education Credentialing, Inc.

This course has been approved by Co-Occurring Collaborative Serving Maine (CCSME), as a NAADAC Approved Education Provider, for 1 educational credits. NAADAC Provider #324712, CCSME is responsible for all aspects of the programming.

Date

Jun 25 2026

Time

12:00 pm - 1:00 pm

More Info

Registration

Category

Registration